Management of functional abdominal pain and irritable bowel syndrome in children and adolescents

References

• Hyams JS, Burke G, Davis PM, Rzepski B, Andrulonis PA. Abdominal pain and irritable bowel syndrome in adolescents: a community-based study. J. Pediatr.129(2), 220–226 (1996).
   PubMed Web of Science ®Google Scholar
• Saps M, Seshadri R, Sztainberg M, Schaffer G, Marshall BM, Di Lorenzo C. A prospective school-based study of abdominal pain and other common somatic complaints in children. J. Pediatr.154(3), 322–326 (2009).
   PubMed Web of Science ®Google Scholar
• Starfield B, Hoekelman RA, McCormick M et al. Who provides health care to children and adolescents in the United States? Pediatrics74(6), 991–997 (1984).
   PubMed Web of Science ®Google Scholar
• Rasquin A, Di Lorenzo C, Forbes D et al. Childhood functional gastrointestinal disorders: child/adolescent. Gastroenterology130(5), 1527–1537 (2006).
   PubMed Web of Science ®Google Scholar
• Longstreth GF, Thompson WG, Chey WD, Houghton LA, Mearin F, Spiller RC. Functional bowel disorders. Gastroenterology130(5), 1480–1491 (2006).
   PubMed Web of Science ®Google Scholar
• Youssef NN, Murphy TG, Langseder AL, Rosh JR. Quality of life for children with functional abdominal pain: a comparison study of patients’ and parents’ perceptions. Pediatrics117(1), 54–59 (2006).
   PubMed Web of Science ®Google Scholar
• Drossman DA, Li Z, Andruzzi E et al. U.S. householder survey of functional gastrointestinal disorders. Prevalence, sociodemography, and health impact. Dig. Dis. Sci.38(9), 1569–1580 (1993).
   PubMed Web of Science ®Google Scholar
• Chitkara DK, Talley NJ, Weaver AL et al. Incidence of presentation of common functional gastrointestinal disorders in children from birth to 5 years: a cohort study. Clin. Gastroenterol. Hepatol.5(2), 186–191 (2007).
   PubMed Web of Science ®Google Scholar
• Campo JV, Di Lorenzo C, Chiappetta L et al. Adult outcomes of pediatric recurrent abdominal pain: do they just grow out of it? Pediatrics108(1), E1 (2001).
   Web of Science ®Google Scholar
• Drossman D. Presidential address: gastrointestinal illness and the biopsychosocial model. Psychosom. Med.60(3), 258–267 (1998).
   PubMed Web of Science ®Google Scholar
• Apley J, Naish N. Recurrent abdominal pains: a field survey of 1,000 school children. Arch. Dis. Child.33(168), 165–170 (1958).
   PubMed Web of Science ®Google Scholar
• Levy RL, Olden KW, Naliboff BD et al. Psychosocial aspects of the functional gastrointestinal disorders. Gastroenterology130(5), 1447–1458 (2006).
   PubMed Web of Science ®Google Scholar
• Saps M, Youssef N, Miranda A et al. Multicenter, randomized, placebo-controlled trial of amitriptyline in children with functional gastrointestinal disorders. Gastroenterology137(4), 1261–1269 (2009).
   PubMed Web of Science ®Google Scholar
• Dearlove J, Dearlove B, Pearl K, Primavesi R. Dietary lactose and the child with abdominal pain. Br. Med. J. (Clin. Res. Ed.)286, 1936 (1983).
   PubMed Web of Science ®Google Scholar
• Lebenthal E, Rossi T, Nord K, Branski D. Recurrent abdominal pain and lactose absorption in children. Pediatrics67(6), 828–832 (1981).
   PubMed Web of Science ®Google Scholar
• Gomara R, Halata M, Newman L et al. Fructose intolerance in children presenting with abdominal pain. J. Pediatr. Gastroenterol. Nutr.47(3), 303–308 (2008).
   PubMed Web of Science ®Google Scholar
• Ford A, Talley N, Spiegel B, Foxx-Orenstein A, Schiller L, Quigley E. Effect of fibre, antispasmodics, and peppermint oil in the treatment of irritable bowel syndrome: systematic review and meta-analysis. Br. Med. J.13(337), a2313 (2008).
   Google Scholar
• Paulo A, Amancio O, de Morais M, Tabacow K. Low-dietary fiber intake as a risk factor for recurrent abdominal pain in children. Eur. J. Clin. Nutr.60(7), 823–827 (2006).
   PubMed Web of Science ®Google Scholar
• Feldman W, McGrath P, Hodgson C, Ritter H, Shipman R. The use of dietary fiber in the management of simple, childhood, idiopathic, recurrent, abdominal pain. Results in a prospective, double-blind, randomized controlled trial. Am. J. Dis. Child.139(12), 1216–1218 (1985).
   PubMedGoogle Scholar
• Huertas-Ceballos AA, Logan S, Bennett C, Macarthur C. Dietary interventions for recurrent abdominal pain (RAP) and irritable bowel syndrome (IBS) in childhood. Cochrane Database Syst. Rev.1, CD003019 (2009).
   Google Scholar
• Christensen M. Recurrent abdominal pain and dietary fiber. Am. J. Dis. Child.140(8), 738–739 (1986).
   PubMedGoogle Scholar
• Hebden JM, Blackshaw E, D’Amato M, Perkins AC, Spiller RC. Abnormalities of GI transit in bloated irritable bowel syndrome: effect of bran on transit and symptoms. Am. J. Gastroenterol.97(9), 2315–2320 (2002).
   PubMed Web of Science ®Google Scholar
• Lin HC. Small intestinal bacterial overgrowth: a framework for understanding irritable bowel syndrome. JAMA292(7), 852–858 (2004).
   PubMed Web of Science ®Google Scholar
• Vandenplas Y, Benninga M. Probiotics and functional gastrointestinal disorders in children. J. Pediatr. Gastroenterol. Nutr.48(Suppl. 2), S107–S109 (2009).
   PubMed Web of Science ®Google Scholar
• Malinen E, Rinttila T, Kajander K et al. Analysis of the fecal microbiota of irritable bowel syndrome patients and healthy controls with real-time PCR. Am. J. Gastroenterol.100(2), 373–382 (2005).
   PubMed Web of Science ®Google Scholar
• Quigley EM. Probiotics in functional gastrointestinal disorders: what are the facts? Curr. Opin. Pharmacol.8(6), 704–708 (2008).
   PubMed Web of Science ®Google Scholar
• Moayyedi P, Ford A, Talley N et al. The efficacy of probiotics in the treatment of irritable bowel syndrome: a systematic review. Gut59(3), 325–332 (2008).
   PubMed Web of Science ®Google Scholar
• Bausserman M, Michail S. The use of Lactobacillus GG in irritable bowel syndrome in children: a double-blind randomized control trial. J. Pediatr.147(2), 197–201 (2005).
   PubMed Web of Science ®Google Scholar
• Gawronska A, Dziechciarz P, Horvath A, Szajewska H. A randomized double-blind placebo-controlled trial of Lactobacillus GG for abdominal pain disorders in children. Aliment. Pharmacol. Ther.25, 177–184 (2007).
   PubMed Web of Science ®Google Scholar
• Bu LN, Chang MH, Ni YH, Chen HL, Cheng CC. Lactobacillus casei rhamnosus Lcr35 in children with chronic constipation. Pediatr. Int.49(4), 485–490 (2007).
   PubMed Web of Science ®Google Scholar
• Lackner JM, Mesmer C, Morley S, Dowzer C, Hamilton S. Psychological treatments for irritable bowel syndrome: a systematic review and meta-analysis. J. Consult. Clin. Psychol.72(6), 1100–1113 (2004).
   PubMed Web of Science ®Google Scholar
• Huertas-Ceballos A, Logan S, Bennett C, Macarthur C. Psychosocial interventions for recurrent abdominal pain (RAP) and irritable bowel syndrome (IBS) in childhood. Cochrane Database Syst. Rev.1, CD003014 (2008).
   Google Scholar
• Brent M, Lobato D, LeLeiko N. Psychological treatments for pediatric functional gastrointestinal disorders. J. Pediatr. Gastroenterol. Nutr.48(1), 13–21 (2009).
   PubMed Web of Science ®Google Scholar
• Bursch B. Psychological/cognitive behavioral treatment of childhood functional abdominal pain and irritable bowel syndrome. J. Pediatr. Gastroenterol. Nutr.47(5), 706–707 (2008).
   PubMed Web of Science ®Google Scholar
• Walker LS, Williams SE, Smith CA, Garber J, Van Slyke DA, Lipani TA. Parent attention versus distraction: impact on symptom complaints by children with and without chronic functional abdominal pain. Pain122(1–2), 43–52 (2006).
   PubMed Web of Science ®Google Scholar
• American Academy of Pediatrics Subcommittee on Chronic Abdominal Pain. Chronic abdominal pain in children. Pediatrics115(3), 812–815 (2005).
   PubMed Web of Science ®Google Scholar
• Ditto B, Eclache M, Goldman N. Short-term autonomic and cardiovascular effects of mindfulness body scan meditation. Ann. Behav. Med.32(3), 227–234 (2006).
   PubMed Web of Science ®Google Scholar
• Bury RG. A study of 111 children with recurrent abdominal pain. Aust. Paediatr. J.23(2), 117–119 (1987).
   PubMedGoogle Scholar
• Youssef N, Rosh J, Loughran M et al. Treatment of functional abdominal pain in childhood with cognitive behavioral strategies. J. Pediatr. Gastroenterol. Nutr.39, 192–196 (2004).
   PubMed Web of Science ®Google Scholar
• Sanders MR, Rebgetz M, Morrison M et al. Cognitive-behavioral treatment of recurrent nonspecific abdominal pain in children: an analysis of generalization, maintenance, and side effects. J. Consult. Clin. Psychol.57(2), 294–300 (1989).
   PubMed Web of Science ®Google Scholar
• Sanders MR, Shepherd RW, Cleghorn G, Woolford H. The treatment of recurrent abdominal pain in children: a controlled comparison of cognitive-behavioral family intervention and standard pediatric care. J. Consult. Clin. Psychol.62(2), 306–314 (1994).
   PubMed Web of Science ®Google Scholar
• Humphreys P, Gevirtz R. Treatment of recurrent abdominal pain: components analysis of four treatment protocols. J. Pediatr. Gastroenterol. Nutr.31(1), 47–51 (2000).
   PubMed Web of Science ®Google Scholar
• Robins PM, Smith SM, Glutting JJ, Bishop CT. A randomized controlled trial of a cognitive-behavioral family intervention for pediatric recurrent abdominal pain. J. Pediatr. Psychol.30(5), 397–408 (2005).
   PubMed Web of Science ®Google Scholar
• Duarte MA, Penna FJ, Andrade EM, Cancela CS, Neto JC, Barbosa TF. Treatment of nonorganic recurrent abdominal pain: cognitive–behavioral family intervention. J. Pediatr. Gastroenterol. Nutr.43(1), 59–64 (2006).
   PubMed Web of Science ®Google Scholar
• Weydert JA, Shapiro DE, Acra SA, Monheim CJ, Chambers AS, Ball TM. Evaluation of guided imagery as treatment for recurrent abdominal pain in children: a randomized controlled trial. BMC Pediatr.6, 29 (2006).
   PubMedGoogle Scholar
• Vlieger A, Menko-Frankenhuis C, Wolfkamp S, Tromp E, Benninga M. Hypnotherapy for children with functional abdominal pain or irritable bowel syndrome. Gastroenterology133(5), 1430–1436 (2007).
   PubMed Web of Science ®Google Scholar
• Anbar RD. Self-hypnosis for the treatment of functional abdominal pain in childhood. Clin. Pediatr. (Phila.)40(8), 447–451 (2001).
   PubMed Web of Science ®Google Scholar
• Lebel AA. Pharmacology. J. Pediatr. Gastroenterol. Nutr.47(5), 703–705 (2008).
   PubMed Web of Science ®Google Scholar
• Ford AC, Talley NJ, Schoenfeld PS, Quigley EM, Moayyedi P. Efficacy of antidepressants and psychological therapies in irritable bowel syndrome: systematic review and meta-analysis. Gut58(3), 367–378 (2009).
   PubMed Web of Science ®Google Scholar
• Bridge JA, Iyengar S, Salary CB et al. Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment: a meta-analysis of randomized controlled trials. JAMA297(15), 1683–1696 (2007).
   PubMed Web of Science ®Google Scholar
• Gutgesell H, Atkins D, Barst R et al. Cardiovascular monitoring of children and adolescents receiving psychotropic drugs: a statement for healthcare professionals from the Committee on Congenital Cardiac Defects, Council on Cardiovascular Disease in the Young, American Heart Association. Circulation99(7), 979–982 (1999).
   PubMed Web of Science ®Google Scholar
• Bahar RJ, Collins BS, Steinmetz B, Ament ME. Double-blind placebo-controlled trial of amitriptyline for the treatment of irritable bowel syndrome in adolescents. J. Pediatr.152(5), 685–689 (2008).
   PubMed Web of Science ®Google Scholar
• Campo J, Perel J, Lucas A et al. Citalopram treatment of pediatric recurrent abdominal pain and comorbid internalizing disorders: an exploratory study. J. Am. Acad. Child Adolesc. Psychiatry43(10), 1234–1242 (2004).
   PubMed Web of Science ®Google Scholar
• Ladabaum U, Sharabidze A, Levin TR et al. Citalopram provides little or no benefit in nondepressed patients with irritable bowel syndrome. Clin. Gastroenterol. Hepatol.8(1), 42–48, e41 (2010).
   PubMed Web of Science ®Google Scholar
• Kline RM, Kline JJ, Di Palma J, Barbero GJ. Enteric-coated, pH-dependent peppermint oil capsules for the treatment of irritable bowel syndrome in children. J. Pediatr.138(1), 125–128 (2001).
   PubMed Web of Science ®Google Scholar
• Sadeghian M, Farahmand F, Fallahi GH, Abbasi A. Cyproheptadine for the treatment of functional abdominal pain in childhood: a double-blinded randomized placebo-controlled trial. Minerva Pediatr.60(6), 1367–1374 (2008).
   PubMedGoogle Scholar
• See MC, Birnbaum AH, Schechter CB, Goldenberg MM, Benkov KJ. Double-blind, placebo-controlled trial of famotidine in children with abdominal pain and dyspepsia: global and quantitative assessment. Dig. Dis. Sci.46(5), 985–992 (2001).
   PubMed Web of Science ®Google Scholar
• Gershon MD, Tack J. The serotonin signaling system: from basic understanding to drug development for functional GI disorders. Gastroenterology132(1), 397–414 (2007).
   PubMed Web of Science ®Google Scholar
• Khoshoo V, Armstead C, Landry L. Effect of a laxative with and without tegaserod in adolescents with constipation predominant irritable bowel syndrome. Aliment. Pharmacol. Ther.23(1), 191–196 (2006).
   PubMed Web of Science ®Google Scholar
• Brandt LJ, Chey WD, Foxx-Orenstein AE et al. An evidence-based position statement on the management of irritable bowel syndrome. Am. J. Gastroenterol.104(Suppl. 1), S1–S35 (2009).
   PubMed Web of Science ®Google Scholar
• Karamanolis G, Tack J. Promotility medications – now and in the future. Dig. Dis.24(3–4), 297–307 (2006).
   PubMed Web of Science ®Google Scholar
• Tack J. Prokinetics and fundic relaxants in upper functional GI disorders. Curr. Opin. Pharmacol.8(6), 690–696 (2008).
   PubMed Web of Science ®Google Scholar
• Drossman DA, Chey WD, Johanson JF et al. Clinical trial: lubiprostone in patients with constipation-associated irritable bowel syndrome – results of two randomized, placebo-controlled studies. Aliment. Pharmacol. Ther.29(3), 329–341 (2009).
   PubMed Web of Science ®Google Scholar
• Cann P, Read N, Holdsworth C, Barends D. Role of loperamide and placebo in management of irritable bowel syndrome (IBS). Dig. Dis. Sci.29, 239–247 (1984).
   PubMed Web of Science ®Google Scholar
• Pimentel M, Park S, Mirocha J, Kane S, Kong Y. The effect of a nonabsorbed oral antibiotic (rifaxamin) on the symptoms of the irritable bowel syndrome: a randomized trial. Ann. Intern. Med.145(8), 557–563 (2006).
   PubMed Web of Science ®Google Scholar
• Pimentel M, Chatterjee S, Chow E, Park S, Kong Y. Neomycin improves constipation-predominant irritable bowel syndrome in a fashion that is dependent of the presence of methane gas: subanalysis of a double-blind randomized controlled study. Dig. Dis. Sci.51(8), 1297–1301 (2006).
   PubMed Web of Science ®Google Scholar
• Huertas-Ceballos A, Logan S, Bennett C, Macarthur C. Pharmacological interventions for recurrent abdominal pain (RAP) and irritable bowel syndrome (IBS) in childhood. Cochrane Database Syst. Rev.1, CD003017 (2008).
   Google Scholar
• Di Lorenzo C, Colletti RB, Lehmann HP et al. Chronic abdominal pain in children: a technical report of the American Academy of Pediatrics and the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition. J. Pediatr. Gastroenterol. Nutr.40(3), 249–261 (2005).
   PubMed Web of Science ®Google Scholar
• Vlieger AM, Blink M, Tromp E, Benninga MA. Use of complementary and alternative medicine by pediatric patients with functional and organic gastrointestinal diseases: results from a multicenter survey. Pediatrics122(2), e446–e451 (2008).
   Web of Science ®Google Scholar
• Day AS. Use of complementary and alternative therapies and probiotic agents by children attending gastroenterology outpatient clinics. J. Paediatr. Child Health38(4), 343–346 (2002).
   PubMed Web of Science ®Google Scholar
• Heuschkel R, Afzal N, Wuerth A et al. Complementary medicine use in children and young adults with inflammatory bowel disease. Am. J. Gastroenterol.97(2), 382–388 (2002).
   PubMed Web of Science ®Google Scholar
• Bensoussan A, Talley NJ, Hing M, Menzies R, Guo A, Ngu M. Treatment of irritable bowel syndrome with Chinese herbal medicine: a randomized controlled trial. JAMA280(18), 1585–1589 (1998).
   PubMed Web of Science ®Google Scholar
• Leung WK, Wu JC, Liang SM et al. Treatment of diarrhea-predominant irritable bowel syndrome with traditional Chinese herbal medicine: a randomized placebo-controlled trial. Am. J. Gastroenterol.101(7), 1574–1580 (2006).
   PubMed Web of Science ®Google Scholar
• Schneider A, Enck P, Streitberger K et al. Acupuncture treatment in irritable bowel syndrome. Gut55(5), 649–654 (2006).
   PubMed Web of Science ®Google Scholar
• Lembo AJ, Conboy L, Kelley JM et al. A treatment trial of acupuncture in IBS patients. Am. J. Gastroenterol.104(6), 1489–1497 (2009).
   PubMed Web of Science ®Google Scholar
• Broide E, Pintov S, Portnoy S, Barg J, Klinowski E, Scapa E. Effectiveness of acupuncture for treatment of childhood constipation. Dig. Dis. Sci.46(6), 1270–1275 (2001).
   PubMed Web of Science ®Google Scholar
• Camilleri M, Chang L. Challenges to the therapeutic pipeline for irritable bowel syndrome: end points and regulatory hurdles. Gastroenterology135(6), 1877–1891 (2008).
   PubMed Web of Science ®Google Scholar